SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-003581
Filing Date
2015-05-07
Accepted
2015-05-07 16:17:01
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q dvax-10q_20150331.htm 10-Q 1307654
2 EX-31.1 dvax-ex311_20150331240.htm EX-31.1 17920
3 EX-31.2 dvax-ex312_20150331241.htm EX-31.2 17828
4 EX-32.1 dvax-ex321_20150331242.htm EX-32.1 6159
5 EX-32.2 dvax-ex322_20150331243.htm EX-32.2 6221
  Complete submission text file 0001564590-15-003581.txt   7208709

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dvax-20150331.xml EX-101.INS 1134385
7 XBRL TAXONOMY EXTENSION SCHEMA dvax-20150331.xsd EX-101.SCH 35723
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dvax-20150331_cal.xml EX-101.CAL 49419
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dvax-20150331_def.xml EX-101.DEF 160277
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20150331_lab.xml EX-101.LAB 345668
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20150331_pre.xml EX-101.PRE 257721
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34207 | Film No.: 15841981
SIC: 2834 Pharmaceutical Preparations